Search

everythinglearnresearchcommunity

for

Search:↓

Fat, bone, and the brain are interconnected in regulating energy and health.

Hair analysis shows low progesterone in anorexia patients, unchanged by short-term weight gain.

Tumescent liposuction reduces waist and hip size but doesn't significantly change metabolic markers, though it may slightly improve blood pressure and certain protein levels.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Zinc supplements may help reduce hair loss caused by levetiracetam without affecting seizure control.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

Fresh plasma transfusions did not help treat Leiner disease in an infant.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Increasing Teneligliptin on his own caused a man's hair loss, which stopped when he ceased the medication.

Interferon therapy is a promising and safe treatment for hepatitis B in Southeast Asia.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

Ritlecitinib can help about 14,000 people with severe hair loss.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

Tirzepatide may improve hair loss by reducing insulin resistance.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.